0001855833-21-000004.txt : 20210419
0001855833-21-000004.hdr.sgml : 20210419
20210419170029
ACCESSION NUMBER: 0001855833-21-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210419
DATE AS OF CHANGE: 20210419
EFFECTIVENESS DATE: 20210419
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RxE2 Inc.
CENTRAL INDEX KEY: 0001855833
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-396332
FILM NUMBER: 21835253
BUSINESS ADDRESS:
STREET 1: 4302 13TH AVE S, STE. 4326
CITY: FARGO
STATE: ND
ZIP: 58103
BUSINESS PHONE: 701-361-7650
MAIL ADDRESS:
STREET 1: 4302 13TH AVE S, STE. 4326
CITY: FARGO
STATE: ND
ZIP: 58103
D
1
primary_doc.xml
X0708
D
LIVE
0001855833
RxE2 Inc.
4302 13TH AVE S, STE. 4326
FARGO
ND
NORTH DAKOTA
58103
701-361-7650
DELAWARE
None
None
Corporation
true
2021
Gerald
E.
Finken
4302 13TH AVE S, STE. 4326
Fago
ND
NORTH DAKOTA
58103
Executive Officer
Director
Chief Executive Officer, Chief Financial Officer and Secretary
Other
Decline to Disclose
- 06b
false
2021-03-31
true
true
true
2021 Equity Incentive Plan
false
0
1
0
1
false
0
0
0
0
false
RxE2 Inc.
/s/ Gerald E. Finken
Gerald E. Finken
CEO
2021-04-19